PIMA541949
Sirukumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541949-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541949 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Sirukumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
CNTO 136
Immunogen
Human IL6
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
2.13 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Sirukumab has been used in trials studying the treatment and basic science of Giant Cell Arteritis and Arthritis, Rheumatoid.
Compare Similar Items
Show Difference
Antigen: Sirukumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CNTO 136
Immunogen: Human IL6
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.13 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Sirukumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CNTO 136
Immunogen:
Human IL6
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.13 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Indatuximab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BT-062; nBT062-DM4
Immunogen: Human SDC1/CD138
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 0.87 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Indatuximab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BT-062; nBT062-DM4
Immunogen:
Human SDC1/CD138
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
0.87 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Caplacizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: ALX-0081; caplacizumab-yhdp; PMP12A2h1-linker AAA-PMP12A2h1; VWF A1 domain
Immunogen: Human VWF A1 domain
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.6 mg/mL
Formulation: 20mM citric acid with 0.01% Tween 80, 6.2% sucrose and no preservative
Host Species: Human
Purification Method: Metal-chelate chromatography
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: __
Antigen:
Caplacizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
ALX-0081; caplacizumab-yhdp; PMP12A2h1-linker AAA-PMP12A2h1; VWF A1 domain
Immunogen:
Human VWF A1 domain
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.6 mg/mL
Formulation:
20mM citric acid with 0.01% Tween 80, 6.2% sucrose and no preservative
Host Species:
Human
Purification Method:
Metal-chelate chromatography
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
__
Antigen: Flanvotumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: 20D7S; IMC-20D7S
Immunogen: Human TYRP1
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.82 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Flanvotumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
20D7S; IMC-20D7S
Immunogen:
Human TYRP1
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.82 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ